Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Similar Posts
Transparency data: Medicines and Healthcare products Regulatory Agency spending over £25,000: 2024 to 2025
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Consultation on the International Council for Harmonisation Guideline E20 for adaptive clinical trial design
The MHRA is consulting with UK stakeholders to gather feedback and comments on ICH E20, a new international guideline.
Field Safety Notices: 23-27 February 2026
List of Field Safety Notices from 23-27 February 2026.
Guidance: Human medicines Modular Manufacture and Point of Care regulations 2025: Overview
Helping interpret the Human Medicines (Amendment) Modular Manufacture and Point of Care regulations 2025.
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
Information for patients, public and healthcare professionals.
First major overhaul of medical device regulation comes into force across Great Britain
New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.